Chesnara Plc: Fourth acquisition in two years
12 November 2026
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector with a specialization in medical instruments and supplies, is making waves with its remarkable growth..
As investors continue to seek opportunities within the dynamic biotechnology sector, Upstream Bio, Inc. (UPB) emerges as a noteworthy contender, particularly for those eyeing companies with..
AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices, is capturing attention with its innovative solutions for peripheral nerve regeneration...
For investors keen on the healthcare sector, particularly in diagnostics and research, Myriad Genetics, Inc. (NASDAQ: MYGN) presents an intriguing opportunity. As a company that offers..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company, is making waves in the biotechnology industry with its innovative approach to drug discovery. Based in..
Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, has caught the attention of investors with its promising pipeline and significant upside potential. Specializing in the..
Celcuity Inc. (NASDAQ: CELC), a pioneering force in the biotechnology sector, is captivating investors with its focus on developing targeted therapies for solid tumors. Headquartered in..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a healthcare sector company specializing in biotechnology, is making waves in the biopharmaceutical industry by developing and commercializing innovative therapies..
In the fast-evolving world of genetic medicine, MeiraGTx Holdings plc (NASDAQ: MGTX) stands out as a promising player, offering innovative treatments for serious diseases. This biotech..
Bicara Therapeutics Inc. (NASDAQ: BCAX), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector with its innovative approach to cancer treatment. Based in Boston,..
Fortrea Holdings Inc. (FTRE) is making waves in the biotechnology sector, currently presenting investors with a tantalizing potential upside of 16.01%. As a U.S.-based contract research..
In the dynamic world of cannabis and consumer products, Tilray Brands, Inc. (NASDAQ: TLRY) stands as a notable player. With its diverse portfolio and international reach,..
For investors with a keen eye on the biotechnology sector, AnaptysBio, Inc. (NASDAQ: ANAB) presents an intriguing opportunity. With its focus on developing cutting-edge immunology therapeutics,..
Opthea Limited (NASDAQ: OPT), a clinical-stage biopharmaceutical company, is generating buzz in the biotech industry with its innovative approach to combating eye diseases. Headquartered in Melbourne,..
Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of savvy investors with a jaw-dropping potential upside of 2,834.28%. As a clinical-stage biotechnology firm, Cel-Sci is carving..
Emergent BioSolutions Inc. (NYSE: EBS) presents a compelling yet complex case for investors seeking opportunities in the healthcare sector, specifically within the specialty and generic drug..
ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector with its promising pipeline of mental health treatments and the potential for substantial..
Personalis, Inc. (NASDAQ: PSNL), a prominent player in the diagnostics and research industry within the healthcare sector, is drawing significant attention from investors, fueled by a..
Keros Therapeutics, Inc. (NASDAQ: KROS) is drawing significant attention in the biotechnology sector, where it is making strides with innovative therapeutics targeting disorders related to the..
For investors looking to explore opportunities in the healthcare sector, Tourmaline Bio, Inc. (NASDAQ: TRML) presents a compelling case with its significant 151.69% potential upside, as..
